Edition:
United Kingdom

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

23.30EUR
24 May 2019
Change (% chg)

€-0.03 (-0.13%)
Prev Close
€23.33
Open
€23.48
Day's High
€23.60
Day's Low
€23.27
Volume
719,503
Avg. Vol
642,925
52-wk High
€28.07
52-wk Low
€21.57

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.60
Market Cap(Mil.): €14,153.45
Shares Outstanding(Mil.): 687.55
Dividend: 0.15
Yield (%): 1.48

Financials

  GRLS.MC Industry Sector
P/E (TTM): 28.04 31.17 35.48
EPS (TTM): 0.83 -- --
ROI: 5.23 12.05 11.75
ROE: 14.00 13.36 16.52

Spain's Grifols, China's Shanghai RAAS form strategic alliance

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019

Spain's Grifols, China's Shanghai RAAS form strategic alliance

March 7 Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019

Earnings vs. Estimates